THERAPEUTIC AREA
saveCardiology
Diseases of the heart and cardiovascular system.
also known as: cardiovascular, cardio, cv, heart
🐶 often sniffed alongside
top 8- tagAdCom616 co-mentions · 607 sources
- tag510(k) Clearance572 co-mentions · 566 sources
- tagRecall165 co-mentions · 45 sources
- tagHematology110 co-mentions · 65 sources
- tagHeart Failure57 co-mentions · 18 sources
- tagUrology53 co-mentions · 3 sources
- tagEndocrinology & Metabolism52 co-mentions · 7 sources
- tagPMA Approval44 co-mentions · 41 sources
drugs
425
catalysts
37
news
2,163
companies
317
Top drugs
view all →Marketed
ALDACTAZIDE
Hepatic Edema
$PFE · 145 catalysts
Marketedadrenaline
Hypotension
113 catalysts
MarketedVALPROIC ACID
Pulmonary Arterial Hypertension
81 catalysts
Marketedtocilizumab
Coronavirus Disease 2019 (COVID-19)
61 catalysts
MarketedHEPARIN SODIUM
$PFE · 53 catalysts
MarketedLaryng-O-Jet
Local Anesthetic Effect
50 catalysts
MarketedGLYCOPYRROLATE
Anesthetic Effect
48 catalysts
Marketedmethylprednisolone sodium succinate
Drug Hypersensitivity Reactions
48 catalysts
🐶 Top companies
view all →Recent catalysts
view all →Apr 30, 2026
phase 2 completion
Dutch Heart Foundation — ghrelin (Phase II Trial Completion)
ghrelin
→
Apr 30, 2026
phase 2 completion
Curtin University — influenza vaccine (Phase II Trial Completion)
influenza vaccine
→
Apr 30, 2026
phase 2 completion
National Institutes of Health — metformin hydrochloride ER (Phase II Trial Completion)
metformin hydrochloride ER
→
Apr 30, 2026
phase 2 completion
Sohag University — ephedrine (Phase II Trial Completion)
ephedrine
→
Apr 30, 2026
phase 2 completion
Neurodawn Pharmaceutical Co Ltd — Loberamisal (Phase II Trial Completion)
Loberamisal
→
Apr 30, 2026
phase 2 completion
Medical University of Gdansk — apixaban (Phase II Trial Completion)
apixaban ODT
→
Apr 30, 2026
phase 2 completion
Cancer Institute and Hospital Chinese Academy of Medical Sciences — lenvatinib (Phase II Trial Completion)
lenvatinib
→
Apr 30, 2026
phase 2 completion
Medanta - The Medicity — centhaquine citrate (Phase II Trial Completion)
centhaquine citrate
→
Apr 30, 2026
phase 2 completion
German Sport University Cologne — polyphenol-rich cocoa extract (Phase II Trial Completion)
polyphenol-rich cocoa extract
→
Apr 30, 2026
phase 1 2 completion
Implicit Bioscience Ltd — Atibuclimab (Phase I/II Trial Completion)
Atibuclimab
→
Recent news
view all →- Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drugbiopharma dive · 4h ago
- Could we one day vaccinate against every cancer?stat · 6h ago
- Opinion: Energy drinks’ new college sports partnerships make them more dangerous than everstat · 9h ago
- Roivant, the 'inveterate drug hunters', enters commercial era with Lisrayabiospace · 14h ago
- FDA signs off on first heart valve designed to dynamically expand in childrenfiercebiotech · 16h ago
- NIH rolling out streamlined website to help public find information more easilystat · 2d ago
- This week in charts: Kodiak’s big comeback and Hengrui’s dealmakingbiopharma dive · 3d ago
- Foghorn cuts 40% of workforcebiospace · 3d ago
Data sources
last refreshed 9h ago
Found something off?
comments(0)
5-min edit window · permanent after that